BioDelivery Sciences (BDSI) Misses Q4 EPS by 36c

March 10, 2016 4:23 PM EST

BioDelivery Sciences (NASDAQ: BDSI) reported Q4 EPS of $0.19, $0.36 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $32.2 million versus the consensus estimate of $52.4 million.

For earnings history and earnings-related data on BioDelivery Sciences (BDSI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings